In case you missed it

• Drug or device? FDA loses this argument for now
• Aptar wins FDA clearance for ready-to-use seizure treatment device
• Aurora Bio touts PET radiotracer data
• Medical device excise tax would reduce R&D spending, report says
• Proteus Digital Health restructuring amid reported funding woes
• GE Healthcare partnering on regenerative tissue manufacturing
• Schiller issues field safety notice for Tempus LS defibrillators
• Report: 3M may sell off its drug-delivery business for $1 billion
• Abbott issues field safety notice for Heartmate 3 LVAS power unit
• Medtronic faces patent lawsuit over CoreValve tech
• Orpyx launches sensory insoles with patient monitoring
• Ortho devicemakers Hensler and Tobra face off in patent lawsuit
• House bill asks CMS to cover breakthrough devices for Medicare patients
• Empirical Spine completes enrollment in LimiFlex pivotal trial
• MolecuLight wins FDA clearance for handheld imaging device
• Medical device tax will cost 20,000 jobs, report says
• W.L. Gore officials think they can spur insulin delivery system innovation